HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful classification of macrophage-mannose receptor CD206 in severity of anti-MDA5 antibody positive dermatomyositis associated ILD.

AbstractOBJECTIVES:
Macrophage-mannose receptor, CD206, is a marker of alternatively activated macrophages. Activated macrophages play key roles in DM. Interstitial lung disease (ILD) is a leading cause of mortality in patients with DM/clinically amyopathic DM (CADM). In particular, patients with the anti-melanoma differential gene 5 antibody (MDA5) frequently develop fatal rapid progressive ILD. This study aimed to evaluate the clinical implications of alternatively activated macrophages in patients with CADM/DM-ILD with anti-MDA5 antibody (MDA5-CADM/DM-ILD).
METHODS:
We measured serum concentrations of soluble CD206 (sCD206) in 33 patients with MDA5-CADM/DM-ILD and 36 age- and sex-matched control subjects. Expression levels of CD206 in the lungs from MDA5-CADM/DM-ILD were also examined.
RESULTS:
Patients with MDA5-CADM/DM-ILD had higher levels of sCD206 than those in controls (P < 0.0001). Of the 33 patients, 10 MDA5-CADM/DM-ILD patients developed fatal respiratory failure. Concentrations of sCD206 in patients with fatal ILD cases were significantly higher than those in the survivors, and increased sCD206 levels were associated with a higher mortality rate (Log-rank test, P = 0.0009). Age- and gender-adjusted logistic regression analyses showed that sCD206 was an independent prognostic factor for MDA5-CADM/DM-ILD. Importantly, assessment by sCD206 together with PaO2 successfully divided into three groups by their prognosis (P < 0.005, respectively). Pathological analyses showed accumulations of CD206-positive macrophages in lungs from the fatal case rather than those in the non-fatal cases.
CONCLUSIONS:
Levels of serum sCD206 are increased in MDA5-CADM/DM-ILD and associated with poor prognosis. sCD206 is a potential biomarker to predict the severity of MDA5-CADM/DM-ILD.
AuthorsYasuoki Horiike, Yuzo Suzuki, Tomoyuki Fujisawa, Hideki Yasui, Masato Karayama, Hironao Hozumi, Kazuki Furuhashi, Noriyuki Enomoto, Yutaro Nakamura, Naoki Inui, Noriyoshi Ogawa, Takafumi Suda
JournalRheumatology (Oxford, England) (Rheumatology (Oxford)) Vol. 58 Issue 12 Pg. 2143-2152 (12 01 2019) ISSN: 1462-0332 [Electronic] England
PMID31143953 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: [email protected].
Chemical References
  • Autoantibodies
  • Lectins, C-Type
  • Mannose Receptor
  • Mannose-Binding Lectins
  • Receptors, Cell Surface
  • IFIH1 protein, human
  • Interferon-Induced Helicase, IFIH1
Topics
  • Aged
  • Autoantibodies (immunology)
  • Dermatomyositis (complications, immunology, metabolism)
  • Female
  • Humans
  • Interferon-Induced Helicase, IFIH1 (immunology)
  • Lectins, C-Type (metabolism)
  • Logistic Models
  • Lung (metabolism, pathology)
  • Lung Diseases, Interstitial (etiology, metabolism)
  • Macrophages (metabolism, pathology)
  • Male
  • Mannose Receptor
  • Mannose-Binding Lectins (metabolism)
  • Middle Aged
  • Prognosis
  • Receptors, Cell Surface (metabolism)
  • Respiratory Insufficiency (etiology, metabolism, mortality)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: